Revolutionary treatment offers Friesian horse a second chance, page-11

Just a few possible drivers of SP growth - mostly from the recent quarterly report.

- MLA expanded sales & marketing team to continue recent OEM healthcare supply agreements
- They commented they were currently in negotiation on further tenders - a bit of a 'who knows when' comment, but could be a big driver if they secure a couple chunky deals, espec given margins of around 50%
- Rights issue, plumped up the account by around 2million.. acquisition? as groberts noted, appointment of CFO
- Further cost reductions, a few one offs in last year's reporting, centralised location & rebound of Clements and core businesses etc
- Medivet: Success with nanofiber, settlement against vet stem and validation by Uni of Kentucky. Recruitment of sales staff in USA & Australia combined and Delk appointed to the board, might lead to an uptake in US procedure numbers?
- Pie funds taking a stake & Lang Walker (billionaire) topping up in the recent rights issue. Ian Mitchell taking full rights entitlement and topping up on market back in July at around 15c.